134 related articles for article (PubMed ID: 16271422)
1. Growth characteristics of canine pathogenic viruses in MDCK cells cultured in RPMI 1640 medium without animal protein.
Mochizuki M
Vaccine; 2006 Mar; 24(11):1744-8. PubMed ID: 16271422
[TBL] [Abstract][Full Text] [Related]
2. Production of canine adenovirus type 2 in serum-free suspension cultures of MDCK cells.
Castro R; Fernandes P; Laske T; Sousa MF; Genzel Y; Scharfenberg K; Alves PM; Coroadinha AS
Appl Microbiol Biotechnol; 2015 Sep; 99(17):7059-68. PubMed ID: 25994255
[TBL] [Abstract][Full Text] [Related]
3. Madin-Darby canine kidney cell sialic acid receptor modulation induced by culture medium conditions: Implications for the isolation of influenza A virus.
Nelson SW; Lorbach JN; Nolting JM; Stull JW; Jackwood DJ; Davis IC; Bowman AS
Influenza Other Respir Viruses; 2019 Nov; 13(6):593-602. PubMed ID: 31392833
[TBL] [Abstract][Full Text] [Related]
4. Cell Bank Origin of MDCK Parental Cells Shapes Adaptation to Serum-Free Suspension Culture and Canine Adenoviral Vector Production.
Rodrigues AF; Fernandes P; Laske T; Castro R; Alves PM; Genzel Y; Coroadinha AS
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854295
[TBL] [Abstract][Full Text] [Related]
5. [Adherent and single-cell suspension culture of Madin-Darby canine kidney cells in serum-free medium].
Huang D; Zhao L; Tan W
Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):645-52. PubMed ID: 21848001
[TBL] [Abstract][Full Text] [Related]
6. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
[TBL] [Abstract][Full Text] [Related]
7. Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.
Huang D; Peng WJ; Ye Q; Liu XP; Zhao L; Fan L; Xia-Hou K; Jia HJ; Luo J; Zhou LT; Li BB; Wang SL; Xu WT; Chen Z; Tan WS
PLoS One; 2015; 10(11):e0141686. PubMed ID: 26540170
[TBL] [Abstract][Full Text] [Related]
8. Continuous-flow ultracentrifugation of canine distemper virus and infectious canine hepatitis virus.
Elliott JA; Ryan WL
Appl Microbiol; 1970 Nov; 20(5):667-71. PubMed ID: 4320861
[TBL] [Abstract][Full Text] [Related]
9. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
Genzel Y; Fischer M; Reichl U
Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
[TBL] [Abstract][Full Text] [Related]
10. Canine bladder epithelial cells in culture: susceptibility to canine distemper and measles viruses.
Bui HD; Tobler LH; Van Pelt LF; Howard EB; Imagawa DT
Am J Vet Res; 1982 Jul; 43(7):1268-70. PubMed ID: 7103210
[TBL] [Abstract][Full Text] [Related]
11. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
12. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
Nakamura K; Harada Y; Takahashi H; Trusheim H; Bernhard R; Hamamoto I; Hirata-Saito A; Ogane T; Mizuta K; Konomi N; Konomi Y; Asanuma H; Odagiri T; Tashiro M; Yamamoto N
Vaccine; 2019 Oct; 37(43):6526-6534. PubMed ID: 31500967
[TBL] [Abstract][Full Text] [Related]
13. Construction of a mavs-inactivated MDCK cell line for facilitating the propagation of canine distemper virus (CDV).
Cai C; Wang X; Zhao Y; Yi C; Jin Z; Zhang A; Han L
Mol Immunol; 2019 Oct; 114():133-138. PubMed ID: 31352229
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of canine distemper virus vaccine produced in a continuous cell line (LLC-MK2 cells).
Lavender JF; Bewsey BJ
Am J Vet Res; 1973 Sep; 34(9):1189-94. PubMed ID: 4355770
[No Abstract] [Full Text] [Related]
15. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
16. Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line.
Peschel B; Frentzel S; Laske T; Genzel Y; Reichl U
Vaccine; 2013 Nov; 31(48):5693-9. PubMed ID: 24113260
[TBL] [Abstract][Full Text] [Related]
17. Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.
Harada Y; Takahashi H; Trusheim H; Roth B; Mizuta K; Hirata-Saito A; Ogane T; Odagiri T; Tashiro M; Yamamoto N
Influenza Other Respir Viruses; 2020 Mar; 14(2):204-209. PubMed ID: 31651085
[TBL] [Abstract][Full Text] [Related]
18. A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal.
Liu S; Li J; Cheng Q; Duan K; Wang Z; Yan S; Tian S; Wang H; Wu S; Lei X; Yang Y; Ma N
Viruses; 2024 May; 16(5):. PubMed ID: 38793649
[TBL] [Abstract][Full Text] [Related]
19. Influence of age and vaccination interval on canine parvovirus, distemper virus, and adenovirus serum antibody titers.
Gonzalez SE; Gogal RM; Meindl AG; Boyer N; Nelson S; Everett SE; Vetter CA; Gonzalez JM
Vet Immunol Immunopathol; 2023 Aug; 262():110630. PubMed ID: 37418822
[TBL] [Abstract][Full Text] [Related]
20. Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.
Hamamoto I; Takahashi H; Shimasaki N; Nakamura K; Mizuta K; Sato K; Nishimura H; Yamamoto N; Hasegawa H; Odagiri T; Tashiro M; Nobusawa E
Microbiol Immunol; 2022 Jul; 66(7):361-370. PubMed ID: 35545856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
